Darrell Shane Lea serves as Executive at Cellectar Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Darrell Shane Lea has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 8, 2023 involved receiving (via award) 39,599 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 8, 2023 | CLRB | $0 | Award | 39,599 | $N/A | Discretionary |
Darrell Shane Lea currently holds 39,599 shares of Cellectar Biosciences, Inc. (CLRB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Darrell Shane Lea has been a net neutral trader of CLRB stock. They have purchased $0 and sold $0 worth of shares.
Darrell Shane Lea's most recent insider trade was on Dec 8, 2023, when they sold 39,599 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted